Results for tag: "Kalbitor"

Kalbitor is a brand of immune disorder drugs used to treat hereditary angioedema (HAE). It is a subcutaneous injection that works by blocking the action of kallikrein, an enzyme that is responsible for the swelling associated with HAE. Kalbitor is the only approved drug for the treatment of HAE in the United States. It is also approved in other countries, including Canada, Australia, and the European Union. Kalbitor is part of a larger market of immune disorder drugs, which includes other treatments for HAE, such as Cinryze and Firazyr. These drugs are used to treat a variety of conditions, including asthma, allergies, and autoimmune diseases. Other drugs in this market include biologics, such as Humira and Enbrel, and small molecule drugs, such as Xolair and Dupixent. Companies in the Kalbitor market include Shire, which manufactures Kalbitor, as well as other pharmaceutical companies such as AbbVie, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of immune disorder drugs. Show Less Read more